Sebastien Roux
Allschwil, BL, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
Journal: Journal of neurosurgery
Published: October 03, 2023
Recurrent myocardial infarction and emergency department visits: a retrospective study on the Stockholm Area Chest Pain Cohort.
Journal: Open heart
Published: November 09, 2022
Longitudinal neuropsychological assessment after aneurysmal subarachnoid hemorrhage and its relationship with delayed cerebral ischemia: a prospective Swiss multicenter study.
Journal: Journal of neurosurgery
Published: November 10, 2021
The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo.
Journal: Journal of clinical medicine
Published: October 13, 2021
Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
Journal: The European respiratory journal
Published: July 06, 2020
Self-treatment for acute coronary syndrome: why not?
Journal: European heart journal
Published: June 20, 2020
Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
Journal: Journal of neurosurgery
Published: December 18, 2019
Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
Journal: World neurosurgery
Published: March 13, 2019
Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the ENABLE Trials.
Journal: JACC. Heart failure
Published: January 13, 2017
Last Updated: 09/26/2026